Global Prenatal Screening Test Market

Prenatal Screening Test Comprehensive Study by Type (Screening Tests (Blood Test, Ultrasound Test), Diagnostic Tests (Amniocentesis Test, Chorionic Villus Sampling Test)), Test Stages (First Trimester Screening Tests (Ultrasound, Early Blood Tests, Chorionic Villus Sampling Test), Second Trimester Screening Tests (Blood Tests, Glucose Screening, Amniocentesis), Third Trimester Screening Tests (Group B Strep Screening, Prenatal Diagnostic Tests)), End User (Hospitals, Gynecology Clinics, Labs) Players and Region - Global Market Outlook to 2026

Prenatal Screening Test Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Prenatal refers to any time during pregnancy. Prenatal Screening Test is used to check the health of the baby during pregnancy. These tests help in detecting problems with the pregnancy as early as possible. It was estimated that in 2015, a total of 303,000 women died due to causes related to pregnancy or childbirth. The majority of these cases were either severe bleeding, sepsis, eclampsia, labor that had some type of obstruction, and consequences from unsafe abortions. This death rate has increased the use of prenatal screening tests during pregnancy to avoid future pregnancy complications. This has driven the demand for the prenatal screening test market.
This growth is primarily driven by Governmental Regulations and Standards for Increasing Use of Prenatal Screening Tests, Increasing Demand Due to Growing Awareness About the Pregnancy Complications and Growing Number of Maternal Death Worldwide.

The Health Care Technology sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Angle Plc (United Kingdom), Hologic, Inc. (United States), PerkinElmer, Inc. (United States), Ravgen, Inc. (India), Beckman Coulter Inc. (United States), Abbott Laboratories (United States), Siemens Healthcare Diagnostics GmbH (Germany), Roche Diagnostics International Ltd (Switzerland) and Thermo Fisher Scientific Inc. (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Market Drivers
  • Governmental Regulations and Standards for Increasing Use of Prenatal Screening Tests
  • Increasing Demand Due to Growing Awareness About the Pregnancy Complications
  • Growing Number of Maternal Death Worldwide

Market Trend

Restraints
  • Some Conditions Cannot Be Detected With a Prenatal Screening Test
  • High Costs of Prenatal Screening Test

Opportunities
Advances in Prenatal Screening Tests and Increasing Demand in Emerging Countries Such as China and India Where Birth Rate Is High

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Prenatal Screening Test Study Sheds Light on
— The Prenatal Screening Test Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Prenatal Screening Test industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Prenatal Screening Test industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Screening Tests [Blood Test, Ultrasound Test]
  • Diagnostic Tests [Amniocentesis Test, Chorionic Villus Sampling Test]
By Test Stages
  • First Trimester Screening Tests [Ultrasound, Early Blood Tests, Chorionic Villus Sampling Test]
  • Second Trimester Screening Tests [Blood Tests, Glucose Screening, Amniocentesis]
  • Third Trimester Screening Tests [Group B Strep Screening, Prenatal Diagnostic Tests]

By End User
  • Hospitals
  • Gynecology Clinics
  • Labs

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Governmental Regulations and Standards for Increasing Use of Prenatal Screening Tests
      • 3.2.2. Increasing Demand Due to Growing Awareness About the Pregnancy Complications
      • 3.2.3. Growing Number of Maternal Death Worldwide
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Prenatal Screening Test, by Type, Test Stages, End User and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Prenatal Screening Test (Value)
      • 5.2.1. Global Prenatal Screening Test by: Type (Value)
        • 5.2.1.1. Screening Tests [Blood Test, Ultrasound Test]
        • 5.2.1.2. Diagnostic Tests [Amniocentesis Test, Chorionic Villus Sampling Test]
      • 5.2.2. Global Prenatal Screening Test by: Test Stages (Value)
        • 5.2.2.1. First Trimester Screening Tests [Ultrasound, Early Blood Tests, Chorionic Villus Sampling Test]
        • 5.2.2.2. Second Trimester Screening Tests [Blood Tests, Glucose Screening, Amniocentesis]
        • 5.2.2.3. Third Trimester Screening Tests [Group B Strep Screening, Prenatal Diagnostic Tests]
      • 5.2.3. Global Prenatal Screening Test by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Gynecology Clinics
        • 5.2.3.3. Labs
      • 5.2.4. Global Prenatal Screening Test Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Prenatal Screening Test (Price)
      • 5.3.1. Global Prenatal Screening Test by: Type (Price)
  • 6. Prenatal Screening Test: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Angle Plc (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Hologic, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. PerkinElmer, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Ravgen, Inc. (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Beckman Coulter Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Abbott Laboratories (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Siemens Healthcare Diagnostics GmbH (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Roche Diagnostics International Ltd (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Thermo Fisher Scientific Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Prenatal Screening Test Sale, by Type, Test Stages, End User and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Prenatal Screening Test (Value)
      • 7.2.1. Global Prenatal Screening Test by: Type (Value)
        • 7.2.1.1. Screening Tests [Blood Test, Ultrasound Test]
        • 7.2.1.2. Diagnostic Tests [Amniocentesis Test, Chorionic Villus Sampling Test]
      • 7.2.2. Global Prenatal Screening Test by: Test Stages (Value)
        • 7.2.2.1. First Trimester Screening Tests [Ultrasound, Early Blood Tests, Chorionic Villus Sampling Test]
        • 7.2.2.2. Second Trimester Screening Tests [Blood Tests, Glucose Screening, Amniocentesis]
        • 7.2.2.3. Third Trimester Screening Tests [Group B Strep Screening, Prenatal Diagnostic Tests]
      • 7.2.3. Global Prenatal Screening Test by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Gynecology Clinics
        • 7.2.3.3. Labs
      • 7.2.4. Global Prenatal Screening Test Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Prenatal Screening Test (Price)
      • 7.3.1. Global Prenatal Screening Test by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Prenatal Screening Test: by Type(USD Million)
  • Table 2. Prenatal Screening Test Screening Tests [Blood Test, Ultrasound Test] , by Region USD Million (2015-2020)
  • Table 3. Prenatal Screening Test Diagnostic Tests [Amniocentesis Test, Chorionic Villus Sampling Test] , by Region USD Million (2015-2020)
  • Table 4. Prenatal Screening Test: by Test Stages(USD Million)
  • Table 5. Prenatal Screening Test First Trimester Screening Tests [Ultrasound, Early Blood Tests, Chorionic Villus Sampling Test] , by Region USD Million (2015-2020)
  • Table 6. Prenatal Screening Test Second Trimester Screening Tests [Blood Tests, Glucose Screening, Amniocentesis] , by Region USD Million (2015-2020)
  • Table 7. Prenatal Screening Test Third Trimester Screening Tests [Group B Strep Screening, Prenatal Diagnostic Tests] , by Region USD Million (2015-2020)
  • Table 8. Prenatal Screening Test: by End User(USD Million)
  • Table 9. Prenatal Screening Test Hospitals , by Region USD Million (2015-2020)
  • Table 10. Prenatal Screening Test Gynecology Clinics , by Region USD Million (2015-2020)
  • Table 11. Prenatal Screening Test Labs , by Region USD Million (2015-2020)
  • Table 12. South America Prenatal Screening Test, by Country USD Million (2015-2020)
  • Table 13. South America Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 14. South America Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 15. South America Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 16. Brazil Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 17. Brazil Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 18. Brazil Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 19. Argentina Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 20. Argentina Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 21. Argentina Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 22. Rest of South America Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 23. Rest of South America Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 24. Rest of South America Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 25. Asia Pacific Prenatal Screening Test, by Country USD Million (2015-2020)
  • Table 26. Asia Pacific Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 27. Asia Pacific Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 28. Asia Pacific Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 29. China Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 30. China Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 31. China Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 32. Japan Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 33. Japan Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 34. Japan Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 35. India Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 36. India Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 37. India Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 38. South Korea Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 39. South Korea Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 40. South Korea Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 41. Taiwan Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 42. Taiwan Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 43. Taiwan Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 44. Australia Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 45. Australia Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 46. Australia Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 47. Rest of Asia-Pacific Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 50. Europe Prenatal Screening Test, by Country USD Million (2015-2020)
  • Table 51. Europe Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 52. Europe Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 53. Europe Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 54. Germany Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 55. Germany Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 56. Germany Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 57. France Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 58. France Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 59. France Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 60. Italy Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 61. Italy Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 62. Italy Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 63. United Kingdom Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 64. United Kingdom Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 65. United Kingdom Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 66. Netherlands Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 67. Netherlands Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 68. Netherlands Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 69. Rest of Europe Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 70. Rest of Europe Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 71. Rest of Europe Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 72. MEA Prenatal Screening Test, by Country USD Million (2015-2020)
  • Table 73. MEA Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 74. MEA Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 75. MEA Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 76. Middle East Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 77. Middle East Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 78. Middle East Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 79. Africa Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 80. Africa Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 81. Africa Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 82. North America Prenatal Screening Test, by Country USD Million (2015-2020)
  • Table 83. North America Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 84. North America Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 85. North America Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 86. United States Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 87. United States Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 88. United States Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 89. Canada Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 90. Canada Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 91. Canada Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 92. Mexico Prenatal Screening Test, by Type USD Million (2015-2020)
  • Table 93. Mexico Prenatal Screening Test, by Test Stages USD Million (2015-2020)
  • Table 94. Mexico Prenatal Screening Test, by End User USD Million (2015-2020)
  • Table 95. Prenatal Screening Test: by Type(USD/Units)
  • Table 96. Company Basic Information, Sales Area and Its Competitors
  • Table 97. Company Basic Information, Sales Area and Its Competitors
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Prenatal Screening Test: by Type(USD Million)
  • Table 106. Prenatal Screening Test Screening Tests [Blood Test, Ultrasound Test] , by Region USD Million (2021-2026)
  • Table 107. Prenatal Screening Test Diagnostic Tests [Amniocentesis Test, Chorionic Villus Sampling Test] , by Region USD Million (2021-2026)
  • Table 108. Prenatal Screening Test: by Test Stages(USD Million)
  • Table 109. Prenatal Screening Test First Trimester Screening Tests [Ultrasound, Early Blood Tests, Chorionic Villus Sampling Test] , by Region USD Million (2021-2026)
  • Table 110. Prenatal Screening Test Second Trimester Screening Tests [Blood Tests, Glucose Screening, Amniocentesis] , by Region USD Million (2021-2026)
  • Table 111. Prenatal Screening Test Third Trimester Screening Tests [Group B Strep Screening, Prenatal Diagnostic Tests] , by Region USD Million (2021-2026)
  • Table 112. Prenatal Screening Test: by End User(USD Million)
  • Table 113. Prenatal Screening Test Hospitals , by Region USD Million (2021-2026)
  • Table 114. Prenatal Screening Test Gynecology Clinics , by Region USD Million (2021-2026)
  • Table 115. Prenatal Screening Test Labs , by Region USD Million (2021-2026)
  • Table 116. South America Prenatal Screening Test, by Country USD Million (2021-2026)
  • Table 117. South America Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 118. South America Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 119. South America Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 120. Brazil Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 121. Brazil Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 122. Brazil Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 123. Argentina Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 124. Argentina Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 125. Argentina Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 126. Rest of South America Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 127. Rest of South America Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 128. Rest of South America Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 129. Asia Pacific Prenatal Screening Test, by Country USD Million (2021-2026)
  • Table 130. Asia Pacific Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 131. Asia Pacific Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 132. Asia Pacific Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 133. China Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 134. China Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 135. China Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 136. Japan Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 137. Japan Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 138. Japan Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 139. India Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 140. India Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 141. India Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 142. South Korea Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 143. South Korea Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 144. South Korea Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 145. Taiwan Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 146. Taiwan Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 147. Taiwan Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 148. Australia Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 149. Australia Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 150. Australia Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 151. Rest of Asia-Pacific Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 152. Rest of Asia-Pacific Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 153. Rest of Asia-Pacific Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 154. Europe Prenatal Screening Test, by Country USD Million (2021-2026)
  • Table 155. Europe Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 156. Europe Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 157. Europe Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 158. Germany Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 159. Germany Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 160. Germany Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 161. France Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 162. France Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 163. France Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 164. Italy Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 165. Italy Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 166. Italy Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 167. United Kingdom Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 168. United Kingdom Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 169. United Kingdom Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 170. Netherlands Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 171. Netherlands Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 172. Netherlands Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 173. Rest of Europe Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 174. Rest of Europe Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 175. Rest of Europe Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 176. MEA Prenatal Screening Test, by Country USD Million (2021-2026)
  • Table 177. MEA Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 178. MEA Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 179. MEA Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 180. Middle East Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 181. Middle East Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 182. Middle East Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 183. Africa Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 184. Africa Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 185. Africa Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 186. North America Prenatal Screening Test, by Country USD Million (2021-2026)
  • Table 187. North America Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 188. North America Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 189. North America Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 190. United States Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 191. United States Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 192. United States Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 193. Canada Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 194. Canada Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 195. Canada Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 196. Mexico Prenatal Screening Test, by Type USD Million (2021-2026)
  • Table 197. Mexico Prenatal Screening Test, by Test Stages USD Million (2021-2026)
  • Table 198. Mexico Prenatal Screening Test, by End User USD Million (2021-2026)
  • Table 199. Prenatal Screening Test: by Type(USD/Units)
  • Table 200. Research Programs/Design for This Report
  • Table 201. Key Data Information from Secondary Sources
  • Table 202. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Prenatal Screening Test: by Type USD Million (2015-2020)
  • Figure 5. Global Prenatal Screening Test: by Test Stages USD Million (2015-2020)
  • Figure 6. Global Prenatal Screening Test: by End User USD Million (2015-2020)
  • Figure 7. South America Prenatal Screening Test Share (%), by Country
  • Figure 8. Asia Pacific Prenatal Screening Test Share (%), by Country
  • Figure 9. Europe Prenatal Screening Test Share (%), by Country
  • Figure 10. MEA Prenatal Screening Test Share (%), by Country
  • Figure 11. North America Prenatal Screening Test Share (%), by Country
  • Figure 12. Global Prenatal Screening Test: by Type USD/Units (2015-2020)
  • Figure 13. Global Prenatal Screening Test share by Players 2020 (%)
  • Figure 14. Global Prenatal Screening Test share by Players (Top 3) 2020(%)
  • Figure 15. Global Prenatal Screening Test share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Angle Plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 18. Angle Plc (United Kingdom) Revenue: by Geography 2020
  • Figure 19. Hologic, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Hologic, Inc. (United States) Revenue: by Geography 2020
  • Figure 21. PerkinElmer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. PerkinElmer, Inc. (United States) Revenue: by Geography 2020
  • Figure 23. Ravgen, Inc. (India) Revenue, Net Income and Gross profit
  • Figure 24. Ravgen, Inc. (India) Revenue: by Geography 2020
  • Figure 25. Beckman Coulter Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Beckman Coulter Inc. (United States) Revenue: by Geography 2020
  • Figure 27. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 28. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 29. Siemens Healthcare Diagnostics GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Siemens Healthcare Diagnostics GmbH (Germany) Revenue: by Geography 2020
  • Figure 31. Roche Diagnostics International Ltd (Switzerland) Revenue, Net Income and Gross profit
  • Figure 32. Roche Diagnostics International Ltd (Switzerland) Revenue: by Geography 2020
  • Figure 33. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2020
  • Figure 35. Global Prenatal Screening Test: by Type USD Million (2021-2026)
  • Figure 36. Global Prenatal Screening Test: by Test Stages USD Million (2021-2026)
  • Figure 37. Global Prenatal Screening Test: by End User USD Million (2021-2026)
  • Figure 38. South America Prenatal Screening Test Share (%), by Country
  • Figure 39. Asia Pacific Prenatal Screening Test Share (%), by Country
  • Figure 40. Europe Prenatal Screening Test Share (%), by Country
  • Figure 41. MEA Prenatal Screening Test Share (%), by Country
  • Figure 42. North America Prenatal Screening Test Share (%), by Country
  • Figure 43. Global Prenatal Screening Test: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Angle Plc (United Kingdom)
  • Hologic, Inc. (United States)
  • PerkinElmer, Inc. (United States)
  • Ravgen, Inc. (India)
  • Beckman Coulter Inc. (United States)
  • Abbott Laboratories (United States)
  • Siemens Healthcare Diagnostics GmbH (Germany)
  • Roche Diagnostics International Ltd (Switzerland)
  • Thermo Fisher Scientific Inc. (United States)
Additional players considered in the study are as follows:
Centogene AG (United States) , Natera, Inc(United States) , Tosoh Bioscience Inc. (United States)
Select User Access Type

Key Highlights of Report


Mar 2022 222 Pages 56 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Prenatal Screening Test Market Quantitative research analysis
Global Prenatal Screening Test Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Prenatal Screening Test market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global Prenatal Screening Test market are Angle Plc (United Kingdom), Hologic, Inc. (United States), PerkinElmer, Inc. (United States), Ravgen, Inc. (India), Beckman Coulter Inc. (United States), Abbott Laboratories (United States), Siemens Healthcare Diagnostics GmbH (Germany), Roche Diagnostics International Ltd (Switzerland) and Thermo Fisher Scientific Inc. (United States), to name a few.
North America is dominating the Prenatal Screening Test Market.

Know More About Global Prenatal Screening Test Market Report?

Have a Query? Click Here

Other Related Reports

Oncology Ablation Comprehensive Study by Type (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Laser Ablation, High-Intensity Focused Ultrasound (HIFU)), Application (Liver Cancer, Kidney ...
$ 3800
Clinical Data Analytics in Healthcare Comprehensive Study by Type (Software, Services), Application (Quality Improvement and Clinical Benchmarking, Clinical Decision Support, Regulatory Reporting and...
$ 3750
Test Tube Baby Comprehensive Study by Type (Reagents (Embryo culture media, Cryopreservation media, Sperm processing media, Ovum processing media), Equipment (Imaging system, Sperm separation system,...
$ 3750
Medical Laser Technology Comprehensive Study by Type (Solid state laser system, Diode laser system, Dye laser system, Gas laser system), Application (Diagnostic, Surgical, Cosmetic, Therapeutic, Dent...
$ 3800
Virtual Reality in Tourism Comprehensive Study by Type (Head Mount Device, Gesture Tracking Device), Application (Travel Agency, Hotel, Tourist Attractions, Other), Video Type (Monoscopic VR Tourism ...
$ 3800
Surgical Simulator Comprehensive Study by Type (Human Patient Simulators, Screen-based simulators), Application (Laparoscopic Surgery, Neurosurgery, Endoscopic Surgery, Trauma Surgery, Cardiac Surger...
$ 3650